Steven Cohen's EXAS Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 180,575 shares of Exact Sciences Corporation (EXAS) worth $18.34 M, representing 0.02% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2015, adding 2.46 M shares. Largest reduction occurred in Q1 2015, reducing 2.32 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +180,575 | New Buy | 180,575 | $101.56 |
| Q1 2025 | -71,192 | Sold Out | 0 | $0.00 |
| Q4 2024 | +71,192 | New Buy | 71,192 | $56.19 |
| Q3 2024 | -195,770 | Sold Out | 0 | $0.00 |
| Q2 2024 | -1.77 M | Reduce 90.06% | 195,770 | $42.25 |
| Q1 2024 | +680,583 | Add 52.79% | 1.97 M | $69.06 |
| Q4 2023 | +921,740 | Add 250.85% | 1.29 M | $73.98 |
| Q3 2023 | -823,485 | Reduce 69.15% | 367,451 | $68.22 |
| Q2 2023 | -288,361 | Reduce 19.49% | 1.19 M | $93.90 |
| Q1 2023 | +305,388 | Add 26.01% | 1.48 M | $67.81 |
| Q4 2022 | -1.26 M | Reduce 51.71% | 1.17 M | $49.51 |
| Q3 2022 | +2.43 M | New Buy | 2.43 M | $32.49 |
| Q2 2022 | -24,100 | Sold Out | 0 | $0.00 |
| Q1 2022 | +24,100 | New Buy | 24,100 | $69.92 |
| Q3 2021 | -14,299 | Sold Out | 0 | $0.00 |
| Q2 2021 | +14,299 | New Buy | 14,299 | $124.34 |
| Q3 2020 | -200,200 | Sold Out | 0 | $0.00 |
| Q2 2020 | +200,200 | New Buy | 200,200 | $86.94 |
| Q3 2019 | -110,898 | Sold Out | 0 | $0.00 |
| Q2 2019 | +105,850 | Add 2096.87% | 110,898 | $118.04 |
| Q1 2019 | -89,552 | Reduce 94.66% | 5,048 | $86.57 |
| Q4 2018 | +94,600 | New Buy | 94,600 | $63.10 |
| Q2 2018 | -576,800 | Sold Out | 0 | $0.00 |
| Q1 2018 | +29,994 | Add 5.49% | 576,800 | $40.33 |
| Q4 2017 | +546,806 | New Buy | 546,806 | $52.54 |
| Q3 2017 | -455,200 | Sold Out | 0 | $0.00 |
| Q2 2017 | -2.05 M | Reduce 81.80% | 455,200 | $35.37 |
| Q1 2017 | +2.35 M | Add 1534.30% | 2.5 M | $23.62 |
| Q4 2016 | +153,000 | New Buy | 153,000 | $13.36 |
| Q3 2016 | -507,175 | Sold Out | 0 | $0.00 |
| Q2 2016 | -240,325 | Reduce 32.15% | 507,175 | $12.25 |
| Q1 2016 | -1.72 M | Reduce 69.72% | 747,500 | $6.74 |
| Q4 2015 | +2.46 M | Add 20473.57% | 2.47 M | $9.23 |
| Q3 2015 | -62,400 | Reduce 83.87% | 12,000 | $18.00 |
| Q2 2015 | -84,500 | Reduce 53.18% | 74,400 | $29.74 |
| Q1 2015 | -2.32 M | Reduce 93.60% | 158,900 | $22.02 |
| Q4 2014 | +2.01 M | Add 430.20% | 2.48 M | $27.44 |
| Q3 2014 | +468,200 | New Buy | 468,200 | $19.38 |
Steven Cohen's Exact Sciences Corporation Investment FAQs
Steven Cohen first purchased Exact Sciences Corporation (EXAS) in Q3 2014, acquiring 468,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Exact Sciences Corporation (EXAS) for 38 quarters since Q3 2014.
Steven Cohen's largest addition to Exact Sciences Corporation (EXAS) was in Q4 2015, adding 2,468,828 shares worth $22.79 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 180,575 shares of Exact Sciences Corporation (EXAS), valued at approximately $18.34 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Exact Sciences Corporation (EXAS) was 2,500,476 shares, as reported at the end of Q1 2017.